Related Experiment Video
Updated: May 12, 2026
05:04
Using Simulation Models to Train Clinicians in the Use of Point-of-Care Ultrasound
Published on: August 9, 2024
Use of a multisource feedback tool to develop pharmacists in a postgraduate training program.
John Graham Davies1, Julienne Ciantar, Barry Jubraj
1Institute of Pharmaceutical Science, King's College London, England, United Kingdom.
American Journal of Pharmaceutical Education
|April 24, 2013
Summary
The pharmacy mini-PAT (peer-assessment tool) effectively tracks junior pharmacist performance, showing significant improvement over time. This tool aids in identifying training needs for early-career pharmacists.
Area of Science:
- Pharmacy education
- Healthcare professional development
- Assessment tools
Background:
- Formal postgraduate training programs are crucial for junior pharmacists.
- Effective performance indicators are needed to guide training and development.
- Peer-assessment tools offer a unique perspective on professional performance.
Purpose of the Study:
- To evaluate the pharmacy mini-PAT (peer-assessment tool) as a performance indicator for junior pharmacists.
- To assess the tool's utility within a formal postgraduate training program in London.
- To analyze changes in performance over time using peer and self-assessments.
Main Methods:
- A 4-year retrospective analysis of data from the pharmacy mini-PAT.
- Bi-annual assessments including junior pharmacist self-evaluations.
- Comparison of assessments by pharmacists, physicians, and nurses.
Main Results:
- Significant improvement in both self-assessment and external assessment scores over time.
- Junior pharmacists consistently rated themselves lower than their assessors (p<0.001).
- Pharmacist assessors rated junior pharmacists lower than other healthcare professionals did (p<0.001).
- The pharmacy mini-PAT demonstrated validity, ease of use, and relevance.
Conclusions:
- The pharmacy mini-PAT is a valuable instrument for junior pharmacist development.
- It serves as an effective formative evaluation tool when used with diverse health professional assessors.
- Mini-PAT results identify specific areas for targeted further training.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:01Feedback Loops
In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...